Comparison of the Time to Recurrence Between Ranibizumab and Aflibercept
NCT02126904
·
clinicaltrials.gov ↗
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
The Injection Burden
Interventions
DRUG:
IVA group
Sponsor
Yokohama City University Medical Center
Collaborators
[object Object]